Practice guidelines regarding psychologists’ involvement in pharmacological issues.
American Psychologist · 2026
DOI: 10.1037/amp0001707 ↗Kurz gefasst
Leitlinie in der Zeitschrift American Psychologist, 2026. Verfasst von David S Shearer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Psychology Health Group. Hauptthemen laut MEDLINE: Psychologists, Psychology, Practice Guidelines as Topic.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Psychology Health Group.
- Master of Science Program in Clinical Psychopharmacology, Marion Turpan College of Psychology and Counseling, Fairleigh Dickinson University.
- Department of Clinical Psychopharmacology, Chicago School.
- Illinois Association of Prescribing Psychologists.
- Master of Science Program in Clinical Psychopharmacology, California School of Professional Psychology, Alliant International University.
ORCID-Profile: David S Shearer
Zitieren
APA
Shearer, D. S., Moore, B. A., Comaty, J. E., LeVine, E. S., Lonning, E., Pujol, L., Rodriguez-Menendez, G., Rom-Rymer, B. N., & Steinman, J. (2026). Practice guidelines regarding psychologists’ involvement in pharmacological issues. American Psychologist. https://doi.org/10.1037/amp0001707
Vancouver
Shearer DS, Moore BA, Comaty JE, LeVine ES, Lonning E, Pujol L, et al. Practice guidelines regarding psychologists’ involvement in pharmacological issues. American Psychologist. 2026. doi:10.1037/amp0001707
BibTeX
@article{Shearer2026,
author = {Shearer, David S and Moore, Bret A and Comaty, Joseph E and LeVine, Elaine S and Lonning, Elizabeth and Pujol, Lynette and Rodriguez-Menendez, Gerardo and Rom-Rymer, Beth N and Steinman, Judi},
title = {Practice guidelines regarding psychologists’ involvement in pharmacological issues},
journal = {American Psychologist},
year = {2026},
doi = {10.1037/amp0001707}
}
EUVIMED